Author

L. G. Thorne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Organism:human· 3 Research Focus:differential expression· 2 Assay:proteomics· 2 Organism:virus· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A.-K. Reuschl· 5 shared C. Jolly· 5 shared G. J. Towers· 5 shared M. V. X. Whelan· 3 shared D. Mesner· 2 shared L. Zuliani-Alvarez· 2 shared M. Noursadeghi· 2 shared A. Garcia-Sastre· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

A.-K. Reuschl

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants

A.-K. Reuschl, L. G. Thorne, M. X. V. Whelan, R. Ragazzini, W. Furnon, V. M. Cowton, G. de Lorenzo, D. Mesner, J. E. Turner, G. Dowgier, N. Bogoda, P. Bonfanti, M. Palmarini, A. H. Patel, C. Jolly, G. J. Towers

This study shows that later Omicron subvariants of SARS-CoV-2, such as BA.4 and BA.5, have evolved enhanced innate immune suppression compared to earlier subvariants like BA.1 and BA.2.

bioRxiv · Jul 12, 2022Microbiology

SARS-CoV-2 Spike evolution influences GBP and IFITM sensitivity

D. Mesner, A.-K. Reuschl, M. V. X. Whelan, T. Bronzovich, T. Haider, L. G. Thorne, G. J. Towers, C. Jolly

This study shows that SARS-CoV-2 variants differ in their sensitivity to GBP and IFITM restriction factors, with Omicron uniquely restricted by these factors due to changes in its spike protein.

bioRxiv · Mar 7, 2022 · PreprintMicrobiology

Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant

L. G. Thorne, M. Bouhaddou, A.-K. Reuschl, L. Zuliani-Alvarez, B. J. Polacco, A. Pelin, J. Batra, M. V. X. Whelan, M. Ummadi, A. Roic, J. Turner, K. Obernier, H. Braberg, M. Soucheray, A. L. Richards, , N. J. Krogan

This study identifies that the B.1.1.7 SARS-CoV-2 variant enhances innate immune evasion through increased Orf9b and Orf6 expression and activity.

bioRxiv · Jun 6, 2021 · PreprintMicrobiology

Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2

S. J. Dicken, M. J. Murray, L. G. Thorne, A.-K. Reuschl, C. Forrest, M. Ganeshalingham, L. Muir, M. D. Kalemera, M. Palor, L. E. McCoy, C. Jolly, G. J. Towers, M. Reeves, J. Grove

This study characterizes the B.1.1.7 and Pangolin coronavirus spike proteins, revealing how NTD mutations enhance viral entry and provide insights into SARS-CoV-2 evolution.

bioRxiv · Mar 22, 2021 · PreprintMicrobiology

SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation

L. G. Thorne, A.-K. Reuschl, L. Zuliani-Alvarez, M. V. X. Whelan, M. Noursadeghi, C. Jolly, G. J. Towers

This study shows SARS-CoV-2 activates RNA sensors in lung epithelial cells, driving macrophage inflammation, which can be mitigated by inhibiting RNA sensing or downstream signaling.

bioRxiv · Dec 23, 2020Microbiology